XKRX:323990 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
13200.00
(+1.93%)
Nov 29
Business Description
Vaxcell-Bio Therapeutics
ISIN : KR7323990002
Share Class Description:
XKRX:323990: Ordinary SharesCompare
Compare
Traded in other countries / regions
323990.Korea IPO Date
2020-09-22Description
Vaxcell-Bio Therapeutics is a bio-technology company engaged in the development of Cell-based and Protein-based Immunotherapeutics for the treatment of cancer.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.41 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 33.2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -6.4 | |||||
| 3-Year EPS without NRI Growth Rate | -5.4 | |||||
| 3-Year FCF Growth Rate | -9.9 | |||||
| 3-Year Book Growth Rate | 1.5 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 88.18 | |||||
| 9-Day RSI | 71.28 | |||||
| 14-Day RSI | 60.36 | |||||
| 6-1 Month Momentum % | -30.43 | |||||
| 12-1 Month Momentum % | -29.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.84 | |||||
| Quick Ratio | 15.84 | |||||
| Days Inventory | 105.54 | |||||
| Days Sales Outstanding | 1.03 | |||||
| Days Payable | 4.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -32 | |||||
| Shareholder Yield % | -0.31 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.57 | |||||
| Operating Margin % | -1892.83 | |||||
| Net Margin % | -1861.18 | |||||
| FCF Margin % | -2388.61 | |||||
| ROE % | -15.01 | |||||
| ROA % | -14.36 | |||||
| ROIC % | -26.93 | |||||
| ROC (Joel Greenblatt) % | -65.21 | |||||
| ROCE % | -10.86 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 562.71 | |||||
| PB Ratio | 4.04 | |||||
| Price-to-Tangible-Book | 4.04 | |||||
| EV-to-EBIT | -34.61 | |||||
| EV-to-EBITDA | -38.51 | |||||
| EV-to-Revenue | 475.7 | |||||
| EV-to-FCF | -19.92 | |||||
| Price-to-Net-Current-Asset-Value | 7.89 | |||||
| Earnings Yield (Greenblatt) % | -2.89 | |||||
| FCF Yield % | -4.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vaxcell-Bio Therapeutics Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 538.758 | ||
| EPS (TTM) (â‚©) | -428.561 | ||
| Beta | 1.63 | ||
| Volatility % | 41.72 | ||
| 14-Day RSI | 60.36 | ||
| 14-Day ATR (â‚©) | 522.192366 | ||
| 20-Day SMA (â‚©) | 12289.5 | ||
| 12-1 Month Momentum % | -29.43 | ||
| 52-Week Range (â‚©) | 11110 - 25200 | ||
| Shares Outstanding (Mil) | 22.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vaxcell-Bio Therapeutics Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vaxcell-Bio Therapeutics Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vaxcell-Bio Therapeutics Frequently Asked Questions
What is Vaxcell-Bio Therapeutics(XKRX:323990)'s stock price today?
The current price of XKRX:323990 is â‚©13200.00. The 52 week high of XKRX:323990 is â‚©25200.00 and 52 week low is â‚©11110.00.
When is next earnings date of Vaxcell-Bio Therapeutics(XKRX:323990)?
The next earnings date of Vaxcell-Bio Therapeutics(XKRX:323990) is .
Does Vaxcell-Bio Therapeutics(XKRX:323990) pay dividends? If so, how much?
Vaxcell-Bio Therapeutics(XKRX:323990) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers